Redefining the treatment of Chagas disease: a review of recent clinical and pharmacological data for a novel formulation of nifurtimox

• Jaime Altcheh ,

  Roles Conceptualization, Data curation, Writing – original draft, Writing – review & editing

  * E-mail: jaltcheh@gmail.com

  Affiliation Hospital de Niños Ricardo Gutiérrez and Instituto Multidisciplinario de Investigacion en Patologias Pediatricas (IMIPP), CONICET-GCBA, Buenos Aires, Argentina

  https://orcid.org/0000-0002-5865-7991

  ⨯
• Ulrike Grossmann,

  Roles Conceptualization, Data curation, Writing – original draft, Writing – review & editing

  Affiliation Bayer AG, Research & Development, Clinical Development & Operations, Acute & Chronic Care & Pediatrics, Berlin, Germany

  ⨯
• Heino Stass,

  Roles Conceptualization, Data curation, Writing – original draft, Writing – review & editing

  Affiliation Bayer AG, Clinical PK CV, Research & Development – Pharmaceuticals, Wuppertal, Germany

  ⨯
• Martin Springsklee,

  Roles Conceptualization, Data curation, Writing – original draft, Writing – review & editing

  Affiliation Bayer AG, Pharmaceuticals, Chief Medical Office, CMO MA Sustainability, Wuppertal, Germany

  ⨯
• Facundo Garcia-Bournissen

  Roles Conceptualization, Data curation, Writing – original draft, Writing – review & editing

  Affiliation Department of Paediatrics, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada

  ⨯